Found: 4
Select item for more details and to access through your institution.
Therapeutic effect of a novel histone deacetylase 6 inhibitor, CKD-L, on collageninduced arthritis in vivo and regulatory T cells in rheumatoid arthritis in vitro.
- Published in:
- Arthritis Research & Therapy, 2017, v. 19, p. 1, doi. 10.1186/s13075-017-1357-2
- By:
- Publication type:
- Article
CKD-506: A novel HDAC6-selective inhibitor that exerts therapeutic effects in a rodent model of multiple sclerosis.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-93232-6
- By:
- Publication type:
- Article
Therapeutic potential of CKD-506, a novel selective histone deacetylase 6 inhibitor, in a murine model of rheumatoid arthritis.
- Published in:
- Arthritis Research & Therapy, 2020, v. 22, n. 1, p. 1, doi. 10.1186/s13075-020-02258-0
- By:
- Publication type:
- Article
Inhibition of histone deacetylase 6 suppresses inflammatory responses and invasiveness of fibroblast-like-synoviocytes in inflammatory arthritis.
- Published in:
- Arthritis Research & Therapy, 2021, v. 23, n. 1, p. 1, doi. 10.1186/s13075-021-02561-4
- By:
- Publication type:
- Article